The National Institute for Health and Care Excellence has issued final guidance backing Sanofi’s Kevzara as a new treatment option for adults with severe, active rheumatoid arthritis (RA). More: Final NICE nod for Sanofi’s Kevzara Source: News
read moreGlaxoSmithKline and Innoviva say their combination lung therapy Anoro Ellipta has come out on top in a trial pitting its effectiveness in improving lung function against that of Boehringer Ingelheim’s Spiolto Respimat. More: GSK’s Anoro Ellipta beats BI’s Spiolto Respimat
read moreA lower dose formulation of Bayer and Janssen’s bloodthinner Xarelto has been approved by European regulators for preventing recurrent venous thromboembolism, expanding treatment options for patients. More: EU OKs low-dose Xarelto to prevent recurrent VTE Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals